Health Condition 1: D180- Hemangioma
Conditions
Interventions
Intervention1: Oral Propranolol: Dosage of 2mg/kg/day, but starting dose is 0.33mg/kg/dose given 8th hourly for the first one week. After the one week follow up visit the dose is doubled to 0.67mg/kg/
Sponsors
Mahatma Gandhi Mission Ethics Committee for Research on Human Subjects
Eligibility
Inclusion criteria
Inclusion criteria: Patient parents willing to undergo treatment and ready to bring the patient for followup. Focal and localized hemangioma.
Exclusion criteria
Exclusion criteria: Patients who have contraindications for beta blockers. Extra cutaneous and multifocal hemangioma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease in size. Change in colour change in consistency Change in surface Change in depth by ultrasoundTimepoint: Once a week for first two weeks, once every two weeks for next two months and then once a month thereafter for 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects of propranolol are hypotension, bradycardia, hyperkalemia, bronchospasm, hypoglycemia, restless sleep, constipation, diarrhea, hypothermia, nausea,vomiting, gastro esophageal reflux and cold extremities.Timepoint: Once a week for first two weeks, once every two weeks for next two months and then once a month thereafter for 6months. | — |
Countries
India
Contacts
Public ContactDr A D Gulanikar
MGM Medical College and Hospital
Outcome results
None listed